Sclerosing fluids to achieve pleurodesis could be hardly replaced for bed-side procedures, but other devices may be successfully applied during thoracoscopy. Thulium Cyber Laser was experimented for this purpose and compared to talc poudrage. Twenty pigs underwent operative videothoracoscopy (VATS). Ten models were subjected to double-port VATS and parietal pleura photoevaporation using Thulium Cyber Laser™ (TCL) 150 W 2010 nm on the posterior third of three ribs; the pleural surface was homogeneously treated inside the target perimeter. The remaining ten pigs underwent uniportal thoracoscopy; talc poudrage was performed using the current clinical practice dosage (1 g/18 kg) with accurate talc powder spread over the whole pleural surface. All models were followed up for 60 days. Pleurodesis firmness was graded on a three-tier scale (none-moderate-firm) and site-matching topographical expectancy was evaluated. TCL produced pleurodesis in all models: 7/10 were firm and 3/10 moderate. Talc poudrage pleurodesis was firm in 4/10 and moderate in 6/10. Pleural adhesions were found exclusively in the treated area after laser treatment, while talc created a wide spectrum of effects, most commonly anarchic jagged adhesions obliterating less than 50 % of the pleural cavity (7/10), mostly declivous. The pathologist found more aggressive inflammation (sometimes severe) in the talc group. Expected localized pleurodesis was always registered in laser group (10/10), while talc poudrage was found poorly effective if consistent pleurodesis is expected in an apico-dorsal position (2/10). Laser pleurodesis appears more homogeneous, qualitatively not inferior, and topographically more predictable than talc pleurodesis. Parietal photoevaporation seems effective and the localized pleurodesis is reproducible.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10103-016-2002-zDOI Listing

Publication Analysis

Top Keywords

talc poudrage
20
thulium cyber
12
pleurodesis
10
talc
9
cyber laser
8
pigs underwent
8
pleural surface
8
localized pleurodesis
8
laser
5
poudrage
5

Similar Publications

Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective.

Curr Oncol

November 2024

Department of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Malignant pleural effusion is the presence of malignant cells within the pleural fluid, representing the second most common cause of pleural exudate. Although diagnostic methods and management techniques for malignant pleural effusion have dramatically improved over the decades, the current treatment is still palliative, aiming to remove pleural fluid, possibly prevent its recurrence, and alleviate symptoms through a wide range of available procedures. Treatment should be tailored to the individual patient, considering comorbidities, size of the effusion, rate of fluid accumulation, underlying cardiac or respiratory conditions, rate of recurrence, presence of loculations or trapped lung, tumor characteristics, cancer type, and patient preferences.

View Article and Find Full Text PDF

The evolving role of medical thoracoscopy on therapeutic management of pleural disease.

Curr Opin Pulm Med

January 2025

Division of Respiratory and Critical Care Medicine. Department of Medicine, National University Hospital, Singapore.

Article Synopsis
  • Medical thoracoscopy (MT) is a less invasive procedure widely accepted for diagnosing and managing pleural diseases, offering advantages for patients who cannot undergo general anesthesia.
  • Recent advancements include new techniques for identifying malignant pleural effusions and the potential benefits of combining MT with talc poudrage and pleural catheter insertion to reduce hospital stays.
  • The review discusses MT's role in treating a range of conditions beyond malignant effusions, including pneumothorax and pleural infections, highlighting its benefits and drawbacks compared to traditional methods for better clinical decision-making.
View Article and Find Full Text PDF

Objective: To assess the feasibility and safety of talc pleurodesis performed as part of day-case medical thoracoscopy.

Methods: A Richard Wolf® 5 mm mini thoracoscope through a 5.5 mm port was used with eligible cases having talc poudrage followed by insertion of indwelling pleural catheter (IPC).

View Article and Find Full Text PDF

Objective: Talc pleurodesis is a widely used treatment option for malignant pleural effusion (MPE). However, the optimal form of administration remains controversial. Thus, we performed a systematic review and meta-analysis to assess the effectiveness of talc slurry (TS) in comparison with thoracoscopic talc insufflation/poudrage (TTI) for MPE treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - Medical thoracoscopy is a safe, minimally invasive procedure primarily used for treating unexplained exudative pleural effusions, but it can also be utilized for pneumothorax (PNX).
  • - A study of 95 patients with various types of PNX showed that those who received at least 4 grams of talc had a significantly lower risk of needing further procedures and experienced less recurrence over two years.
  • - The results indicate that medical thoracoscopy is effective for acute PNX treatment with potential for long-term success, but further large-scale studies are necessary to solidify its role in clinical practice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!